A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a phase II randomised, multicentre, prospective, open label clinical trial. The trial aims to recruit patients who test positive for COVID-19 who have mild symptoms and therefore can treat their symptoms in the community. Patients who test positive for COVID-19 at hospital may also be able to participate.
Epistemonikos ID: 9ed7e5ed82671e719cfdc73ddd7c8f80d484973d
First added on: Jul 03, 2020